Combined tDCS and Vision Restoration Training in Post-acute Stroke: an Exploratory Efficacy and Safety Study
NCT ID: NCT02703870
Last Updated: 2016-03-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1/PHASE2
19 participants
INTERVENTIONAL
2013-03-31
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Combined tDCS and Vision Restoration Training in Subacute Stroke Rehabilitation: A Pilot Study
NCT02935413
Combining tDCS With VR-based Motor Training in Stroke
NCT03144102
Neuroregeneration Enhanced by Transcranial Direct Current Stimulation (TDCS) in Stroke
NCT00909714
Non-invasive Current Stimulation for Restoration of Vision
NCT04008589
tDCS on Motor Rehabiliation of Post Stroke Patients
NCT03446378
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
19 post-acute stroke homonymous hemianopia patients were randomly assigned to either 10 sessions of combined rea-tDCS (2mA, 10 daily sessions of 15-20 min) and VRT, or sham-tDCS and VRT. The primary outcome criterion was the pre-post change in perimetric detection thresholds. Secondary outcome is neurophysiological changes in EEG measures (VEP, Connectivity, Spectral Power, ...)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Verum tDCS
Verum group receiving complete treatment of tDCS
verum tDCS
real transcranial direct current stimulation,10 sessions, 2mA for 20 minutes
VRT
Vision restoration training, 10 sessions, 20 minutes
sham tDCS
Sham group receiving sham tDCS
sham tDCS
sham transcranial direct current stimulation, 10 sessions, for 20 minutes
VRT
Vision restoration training, 10 sessions, 20 minutes
real VRT
Real Vision Restoration Training
verum tDCS
real transcranial direct current stimulation,10 sessions, 2mA for 20 minutes
sham tDCS
sham transcranial direct current stimulation, 10 sessions, for 20 minutes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
verum tDCS
real transcranial direct current stimulation,10 sessions, 2mA for 20 minutes
sham tDCS
sham transcranial direct current stimulation, 10 sessions, for 20 minutes
VRT
Vision restoration training, 10 sessions, 20 minutes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Visual Field Defect
* Lesion age 4 weeks up to 6 month max.
Exclusion Criteria
* Metal artefacts in head
* Epilepsy
* Visual Neglect
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Neurologisches Therapiezentrum Gmundnerberg
OTHER
University of Magdeburg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bernhard A. Sabel
Prof. Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bernhard A Sabel, Prof. Dr.
Role: STUDY_DIRECTOR
Institute of Medical Psychology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Neurologisches Therapiezentrum Gmundnerberg
Altmünster, , Austria
Inst. f. Medical Psychology, Univ. of Magdeburg
Magdeburg, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CES_NTG_1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.